These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33112350)

  • 1. Multifunctional nanoparticles for targeting the tumor microenvironment to improve synergistic drug combinations and cancer treatment effects.
    Chen ML; Lai CJ; Lin YN; Huang CM; Lin YH
    J Mater Chem B; 2020 Dec; 8(45):10416-10427. PubMed ID: 33112350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Delivery of Natural Compounds with a Dual-Targeted Nanoparticle Delivery System for Improving Synergistic Therapy in an Orthotopic Tumor Model.
    Chu PY; Tsai SC; Ko HY; Wu CC; Lin YH
    ACS Appl Mater Interfaces; 2019 Jul; 11(27):23880-23892. PubMed ID: 31192580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
    Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
    Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
    Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active Tumor-Targeted co-Delivery of Epigallocatechin Gallate and Doxorubicin in Nanoparticles for Combination Gastric Cancer Therapy.
    Mi FL; Wang LF; Chu PY; Peng SL; Feng CL; Lai YJ; Li JN; Lin YH
    ACS Biomater Sci Eng; 2018 Aug; 4(8):2847-2859. PubMed ID: 33435008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
    Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
    J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
    Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
    Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
    J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells.
    Eom DW; Lee JH; Kim YJ; Hwang GS; Kim SN; Kwak JH; Cheon GJ; Kim KH; Jang HJ; Ham J; Kang KS; Yamabe N
    BMB Rep; 2015 Aug; 48(8):461-6. PubMed ID: 25441423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle Targeting CD44-Positive Cancer Cells for Site-Specific Drug Delivery in Prostate Cancer Therapy.
    Huang WY; Lin JN; Hsieh JT; Chou SC; Lai CH; Yun EJ; Lo UG; Pong RC; Lin JH; Lin YH
    ACS Appl Mater Interfaces; 2016 Nov; 8(45):30722-30734. PubMed ID: 27786455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
    Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
    Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier-Enhanced Anticancer Efficacy of Sunitinib-Loaded Green Tea-Based Micellar Nanocomplex beyond Tumor-Targeted Delivery.
    Yongvongsoontorn N; Chung JE; Gao SJ; Bae KH; Yamashita A; Tan MH; Ying JY; Kurisawa M
    ACS Nano; 2019 Jul; 13(7):7591-7602. PubMed ID: 31262169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic synthesis of PEG-poly(amine-co-thioether esters) as highly efficient pH and ROS dual-responsive nanocarriers for anticancer drug delivery.
    Gong YH; Shu M; Xie JH; Zhang C; Cao Z; Jiang ZZ; Liu J
    J Mater Chem B; 2019 Jan; 7(4):651-664. PubMed ID: 32254798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
    Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
    Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition.
    Chen D; Lian S; Sun J; Liu Z; Zhao F; Jiang Y; Gao M; Sun K; Liu W; Fu F
    Drug Deliv; 2016; 23(3):808-13. PubMed ID: 24892632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy.
    Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
    Int J Biol Macromol; 2019 Apr; 126():662-672. PubMed ID: 30599159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
    Tang P; Sun Q; Yang H; Tang B; Pu H; Li H
    Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment-labile polymer-doxorubicin conjugate thermogel combined with docetaxel for in situ synergistic chemotherapy of hepatoma.
    Zhang Y; Zhang J; Xu W; Xiao G; Ding J; Chen X
    Acta Biomater; 2018 Sep; 77():63-73. PubMed ID: 30006312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.